BRAIN Biotech AG
Stephanie Konle is a seasoned professional in public relations and corporate communications with extensive experience in the life sciences sector. Currently serving as the Senior Manager of PR & Corporate Communications at BRAIN Biotech AG since February 2020, Stephanie has held significant roles at various organizations, including Chefredakteurin LABO at Weka Business Medien GmbH and PR-/e-Media Manager at Merck Group. Previous positions include work in public relations and marketing for Immundiagnostik AG and a management role at BioRN Life Science Cluster Rhine-Neckar. Stephanie's academic background includes two Diplom degrees in Biology from Ulm University and the University of Hohenheim.
This person is not in any offices
BRAIN Biotech AG
BRAIN Biotech AG is a leading European supplier of biobased products and solutions such as enzymes and proteins, microbial production strains, natural compounds and biotechnological solutions for more sustainable industrial processes. We focus on the fields of nutrition, health and environment. BRAIN Biotech AG is the parent company of the international BRAIN Biotech Group. The Group's business activities are divided into the segments BioProducts, BioScience and BioIncubator. The BioProducts segment comprises the product business with specialty enzymes and other proteins, for which the Group operates fermentation facilities in the United Kingdom and production facilities in continental Europe and the United States. The BioScience segment offers research-intensive custom solutions based on enzyme technology, strain development, bioprocess development and natural product screening. The BioIncubator segment conducts its own R&D projects or those initiated with partners with high value-added potential. A particularly promising incubator project is the development of the Company's own CRISPR-based gene editing technology platform, which is currently being established and expanded.